AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2016

Jan 20, 2016

33819_dirs_2016-01-20_6791ff81-973c-416b-946c-9978ad571910.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-01-18

Reporting Person: Massey Ian J (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-18	Common Stock	A	1250000	$0.00	Acquired	2000000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17059	Indirect

Footnotes

F1: Restricted stock units with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical study in spinal cord injury.

F2: Consists of 2,000,000 restricted stock units with performance based vesting.

F3: Includes shares held in 401(k) account in accordance with issuer's employer-match policies.